Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENND3 antisense RNA 1 (DENND3-AS1) is a putative long non-coding RNA gene transcribed from the antisense strand of the DENND3 locus. Its symbol and name indicate it is likely to have a regulatory relationship with the sense gene DENND3, such as modulation of mRNA stability, splicing, or translation, but there is currently no published experimental data defining its molecular function, physiological role, disease associations, or suitability as a therapeutic target[4][5]. It is not considered a classical therapeutic target such as a receptor, enzyme, or transporter. If your goal is to map druggable therapeutic targets, DENND3-AS1 is not appropriate as it is not known to encode a protein or function as a direct drug target. Most available research and biological knowledge concern the protein-coding gene DENND3 rather than DENND3-AS1[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENND3 antisense RNA 1 (DENND3-AS1).